A Case of Native Medicine Induced Hypomyopathic Dermatomyositis

Article Sidebar

Showing Violaceous Erythematous Papules Over the Right
PDF
Published: Jan 27, 2023
Keywords:
Hypomyopathic Dermatomyositis

Main Article Content

Sanjeevi Krishnan P.
Junior Resident, Department of General Medicine, Sree Balaji Medical College and Hospital, Chromepet, Chennai, Tamil Nadu 600044, India.
K. Shanmuganandan
Professor, Department of General Medicine, Sree Balaji Medical College and Hospital, Chromepet, Chennai, Tamil Nadu 600044, India.

Abstract

Dermatomyositis (DM) is a type of inflammatory myopathy, idiopathic in origin, commonly presenting with progressive and symmetrical proximal muscle weakness with characteristic cutaneous manifestations. Skin features may develop even in the absence of outright myopathy that can persist even after successful treatment [1]. Here we present a case of 38-year-old female who presented with photosensitive erythematous papules over the face, trunk and upper limbs after intake of native medicine for her varicose veins.

Article Details

How to Cite
Krishnan P., S. ., & Shanmuganandan, K. . (2023). A Case of Native Medicine Induced Hypomyopathic Dermatomyositis. Journal of Coastal Life Medicine, 11(1), 219–223. Retrieved from https://www.jclmm.com/index.php/journal/article/view/314
Issue
Vol. 11: Number 1, 2023
Section
Articles

References

Kalyan M, Kanitkar S, Gaikwad A, Kumar H. Dermatomyositis: a case report. J Mahatma Gandhi Inst Med Sci. 2016;21(1):53–55. doi:10.4103/0971-9903.178107.

Marvi U, Chung L, Fiorentino DF. Clinical presentation and evaluation of dermatomyositis. Indian J Dermatol. 2012;57(5):375–381. doi:10.4103/0019-5154.100486.

Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54(4):597–613. doi:10.1016/j. jaad.2005.10.041

Dourmishev A, Dourmishev L. Dermatomyositis and drugs. Adv Exp Med Biol 1999; 455: 187–191.

Dourmishev LA, Stomonjakova SR, Dourmishev AL. D-penicillamine induced polymyositis and morphea dissemination in woman with Hashimoto thyreoiditis. J Eur Acad Dermatol Venereol 2002; 16: 538–539.

Hundley JL, Carroll CL, Lang W, et al. Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. J Am Acad Dermatol 2006; 54:217.

Sontheimer RD. The management of dermatomyositis: current treatment options. Expert Opin Pharmacother 2004; 5:1083.

Iorizzo LJ 3rd, Jorizzo JL. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol 2008; 59:99.

Cheong WK, Hughes GR, Norris PG, Hawk JL. Cutaneous photosensitivity in dermatomyositis. Br J Dermatol 1994; 131:205.

Hamaguchi Y, Kuwana M, Hoshino K, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult japanese patients with dermatomyositis: a multicenter cross-sectional study. JAMA Dermatol. 2011;147(4):391–398. doi:10.1001/archdermatol.2011.52.